194 related articles for article (PubMed ID: 34911528)
21. Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis.
Matraiah EH; Olisaka N; Philipos M; Walbaum D; Dospinescu P; Fluck N; Basu N; Kidder D
Clin Rheumatol; 2018 Jul; 37(7):1991-1996. PubMed ID: 29808456
[TBL] [Abstract][Full Text] [Related]
22. Clinical descriptive analysis of severe
Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
[No Abstract] [Full Text] [Related]
23. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for
Viceconte G; Buonomo AR; D'Agostino A; Foggia M; Di Fusco A; Pinchera B; Scotto R; Iacovazzo C; Fanasca L; Messina G; Cacciatore F; Salvatore P; Gentile I; On Behalf Of The Federico Ii Covid Team
J Fungi (Basel); 2023 Aug; 9(8):. PubMed ID: 37623609
[TBL] [Abstract][Full Text] [Related]
25. Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.
Goto N; Futamura K; Okada M; Yamamoto T; Tsujita M; Hiramitsu T; Narumi S; Watarai Y
Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):81-90. PubMed ID: 26609250
[TBL] [Abstract][Full Text] [Related]
26. Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.
Haeusler GM; Slavin MA; Seymour JF; Lingaratnam S; Teh BW; Tam CS; Thursky KA; Worth LJ
Eur J Haematol; 2013 Aug; 91(2):157-63. PubMed ID: 23668894
[TBL] [Abstract][Full Text] [Related]
27. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
Sarwar S; Carey B; Hegarty JE; McCormick PA
Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
[TBL] [Abstract][Full Text] [Related]
28. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
29. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
[TBL] [Abstract][Full Text] [Related]
30. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
Yau AA; Farouk SS
BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
[TBL] [Abstract][Full Text] [Related]
31. Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients.
Phipps LM; Chen SC; Kable K; Halliday CL; Firacative C; Meyer W; Wong G; Nankivell BJ
Transplantation; 2011 Dec; 92(12):1327-34. PubMed ID: 22129760
[TBL] [Abstract][Full Text] [Related]
32. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
[TBL] [Abstract][Full Text] [Related]
34. Post-COVID-19
Niamatullah H; Nasir N; Jabeen K; Rattani S; Farooqi J; Ghanchi N; Irfan M
Access Microbiol; 2023; 5(1):acmi000406. PubMed ID: 36860506
[No Abstract] [Full Text] [Related]
35. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
[TBL] [Abstract][Full Text] [Related]
36. VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report.
Jia L; Zhang Z; Bai Y; Du Q
Medicine (Baltimore); 2022 Jan; 101(1):e28482. PubMed ID: 35029898
[TBL] [Abstract][Full Text] [Related]
37. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
38. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
[TBL] [Abstract][Full Text] [Related]
39. Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients.
Xu J; Yu Y; Lv J; Yang S; Wu J; Chen J; Peng W
Ann Transplant; 2021 Jun; 26():e931059. PubMed ID: 34099614
[TBL] [Abstract][Full Text] [Related]
40. Concurrent COVID-19 and
Anggraeni AT; Soedarsono S; Soeprijanto B
Radiol Case Rep; 2021 Dec; 16(12):3685-3689. PubMed ID: 34630801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
